Image
  • Company
  • Therapeutic Solution
  • Technology
  • Platform
  • Intellectual Property
  • Contact
  • News

Lumeda is advancing a new therapy to improve treatment outcomes and extend survival of patients with lung cancer

✧ Learn about our therapeutic solution

Lumeda DigiLum™ - A new paradigm in photodynamic therapy

Breakthrough Innovation in PDT to spur its adoption and clinical utility

✧ Learn more about our platform

A BETTER IMMUNE ADJUVANT

Working in synergy with immune checkpoint inhibitors to improve response and extend benefits to more patients without toxicities or side effects✧ Learn more about our combination therapy

    TEAM

    We are a multidisciplinary team of professionals with decades of industry experience augmented with a distinguished group of scientific, clinical, and oncology drug development advisors.

    Learn More >

    PARTNERS

    We are proud to be working with leaders in the thoracic surgery and medical oncology departments of leading cancer centers along with pharmaceutical partners on our preclinical and clinical studies.

    Learn More >

    CLINICAL STUDIES

    We have implemented a clinical plan with two Phase I clinical studies currently open for initial prove-out of our therapeutic solution in treating patients with advanced lung cancer.      

    Learn More >

    © 2022 Lumeda Inc. All Rights Reserved

    • Company
    • Team
    • Therapeutic Solution
    • Technology
    • Platform
    • Contact
    • News
    DigiLum PDT: Unleashing the Power of Immunotherapy for Lung Cancer Patients
    WATCH NOW
    close-image